Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

3.4K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A tale of two transferrin receptors.

Blood·2026
Same author

Hormonal Profile and Anthropometric Indices As Determinants of Metabolic Risk in Polycystic Ovary Syndrome: A Prospective Observational Study.

Cureus·2026
Same author

High-fat diet causes rapid loss of intestinal group 3 innate lymphoid cells through microbiota-driven inflammation and mitochondrial stress.

Immunity·2026
Same author

Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD).

Kidney international·2026
Same author

<sup>18</sup>F-FPP-RGD<sub>2</sub> PET Imaging for Interrogating Target Engagement and Antifibrotic Activity of an Integrin Antagonist in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Hemochromatosis Proteins Hemojuvelin and Homeostatic Iron Regulator in Bone Morphogenetic Protein-Mediated Hepcidin Regulation and Iron Homeostasis.

American journal of hematology·2025

Related Experiment Video

Updated: Aug 6, 2025

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.1K

A Rationally Designed Complex Replenishes the Transferrin Iron Pool Directly and with High Specificity.

Artur Sargun1, Allison L Fisher2, Anna S Wolock1

  • 1Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts 02114-2696, United States.

Journal of the American Chemical Society
|March 15, 2023
PubMed
Summary
This summary is machine-generated.

A novel iron (Fe) complex, Fe-BBG, effectively treats anemia by directly replenishing iron levels in transferrin. This targeted approach bypasses ferroportin, offering a promising new therapy for iron-restricted anemias.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.6K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

525

Related Experiment Videos

Last Updated: Aug 6, 2025

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.1K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.6K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

525

Area of Science:

  • Biochemistry
  • Pharmacology
  • Hematology

Background:

  • Anemia is often caused by impaired iron (Fe) transport due to reduced ferroportin activity.
  • This ferroportin dysfunction limits iron delivery to bone marrow, complicating anemia treatment.
  • Current iron supplementation methods face challenges due to the ferroportin-transferrin axis.

Purpose of the Study:

  • To design and evaluate a novel iron complex (Fe-BBG) for targeted iron replenishment.
  • To optimize Fe-BBG's properties for rapid and precise iron delivery to transferrin.
  • To assess Fe-BBG's efficacy and safety in an anemia model.

Main Methods:

  • Coordination chemistry principles were used to design the Fe-BBG complex.
  • Solution thermodynamics and iron dissociation kinetics were optimized.
  • Fe-BBG efficacy was tested in a mouse model of iron-refractory iron-deficiency anemia.
  • Safety was assessed by monitoring clinical chemistry and gene expression related to oxidative stress and inflammation.

Main Results:

  • Fe-BBG demonstrated optimized thermodynamics and kinetics for rapid transferrin iron replenishment.
  • The complex was unreactive towards redox cycling and reactive oxygen species production.
  • Fe-BBG successfully corrected anemia in a mouse model.
  • No adverse clinical chemistry changes or signs of oxidative stress/inflammation were observed.

Conclusions:

  • Fe-BBG represents a new class of transferrin-targeted iron replacement drugs.
  • This approach effectively bypasses ferroportin-mediated iron transport limitations.
  • Fe-BBG shows promise as a safe and effective therapeutic for specific anemias.